We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Nova Biomedical

Nova is a world leader in the development and manufacturing of whole blood, point-of-care and critical care analyzers... read more Featured Products: More products

Download Mobile App





Nova Biomedical Presents POC and Critical Care Whole Blood IVD Testing Solutions

By LabMedica International staff writers
Posted on 13 Nov 2023
Print article
Image: Nova Biomedical is exhibiting at MEDICA 2023 at Hall 3/ C16-2 (Photo courtesy of Nova Biomedical)
Image: Nova Biomedical is exhibiting at MEDICA 2023 at Hall 3/ C16-2 (Photo courtesy of Nova Biomedical)

Nova Biomedical (Waltham, MA, USA) is presenting its range of point of care (POC) and critical care whole blood in vitro diagnostic testing solutions at MEDICA 2023.

Nova Biomedical is demonstrating the Stat Profile Prime Plus Critical Care analyzer which recently received the U.S. Food and Drug Administration (FDA) 510(k) clearance for a microcapillary sample mode. Prime Plus now performs an 11-test panel including pH, PCO2, PO2, Na, K, iCa, iMg, Cl, glucose, lactate, and hematocrit with just 90 microliters of capillary blood, or a complete 22-test profile on just 135 microliters of blood. The use of small-volume microcapillary blood collection tubes with Prime Plus eliminates sample over-draws, dead volume, and sample waste from syringe or vacuum tube devices. Prime Plus comprehensive test menu enables scheduled bundling of tests to eliminate multiple sample draws, use of multiple sample containers, and amount of blood drawn for critical care testing.

Nova Biomedical’s StatStrip Glucose Hospital Meter System is also being exhibited at MEDICA 2023. The StatStrip Glucose and StatStrip Glucose/Ketone meters are specifically designed for the detection and management of dysglycemia throughout all professional healthcare settings including critical care. Also on display at the event are the StatStrip and StatStrip Xpress2 Lactate, Hemoglobin, and Hematocrit Meter Systems which provide lactate results in only 13 seconds from a 0.6 microliter capillary blood sample, and hemoglobin and hematocrit results in 40 seconds from a 1.6 microliter capillary blood sample. StatStrip Lac/Hb/Hct meter system can connect to laboratory information systems (LIS) and electronic medical records (EMR) while the Xpress2 Lac/Hb/Hct is designed for applications that do not require connectivity.

All results offer excellent correlation to laboratory reference methods and testing with a StatStrip or Xpress2 Lac/Hb/Hct meter system is as easy as glucose self-testing. StatStrip and StatStrip Xpress2 Lac/Hb/Hct systems offer fast, point-of-care (POC) testing with single-use, disposable biosensors, tiny capillary blood samples, and easy-to-read, color display screens. The meters enable rapid, affordable lactate, hemoglobin, and hematocrit testing for any size emergency department, intensive care unit, or medical unit, as well as in pre-hospital, ambulance, and military care situations.

Related Links:
Nova Biomedical 

Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
New
Gold Member
Veterinary Hematology Analyzer
Exigo H400
New
H.pylori Test
Humasis H.pylori Card
New
Mycoplasma Pneumoniae Virus Test
Mycoplasma Pneumoniae Virus Detection Kit

Print article

Channels

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Pathology

view channel
Image: The skin-based test can detect signature features of progressive supranuclear palsy (Photo courtesy of 123RF)

Skin-Based Test to Improve Diagnosis of Rare, Debilitating Neurodegenerative Disease

In neurodegenerative diseases, misfolded proteins, such as alpha synuclein or tau, accumulate in brain and nervous system cells, leading to cell damage and neurodegeneration. While researchers have successfully... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.